☰

Jennitte L. Stevens, Ph.D. - Publications

Affiliations: 
2002 University of California, Los Angeles, Los Angeles, CA 
Area:
Molecular Biology, Genetics
Tree Info Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Spahr CS, Daris ME, Graham KC, Soriano BD, Stevens JL, Shi SD. Discovery, characterization, and remediation of a C-terminal Fc-extension in proteins expressed in CHO cells. Mabs. PMID 30148415 DOI: 10.1080/19420862.2018.1511197  0.307
2018 Shi SY, Lu YW, Liu Z, Stevens J, Murawsky CM, Wilson V, Hu Z, Richards WG, Michaels ML, Zhang J, Yan W, Li Y. A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity. The Journal of Biological Chemistry. PMID 29483191 DOI: 10.1074/Jbc.Ra118.001752  0.353
2012 Wu X, Weiszmann J, Ge H, Baribault H, Stevens J, Hawkins N, Vonderfecht S, Gardner J, Gupte J, Sheng J, Wang M, Li Y. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho. Journal of Molecular Biology. 418: 82-9. PMID 22370560 DOI: 10.1016/J.Jmb.2012.02.027  0.327
2012 Yie J, Wang W, Deng L, Tam LT, Stevens J, Chen MM, Li Y, Xu J, Lindberg R, Hecht R, Véniant M, Chen C, Wang M. Understanding the physical interactions in the FGF21/FGFR/β-Klotho complex: structural requirements and implications in FGF21 signaling. Chemical Biology & Drug Design. 79: 398-410. PMID 22248288 DOI: 10.1111/J.1747-0285.2012.01325.X  0.325
2011 Shalhoub V, Ward SC, Sun B, Stevens J, Renshaw L, Hawkins N, Richards WG. Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization. Calcified Tissue International. 89: 140-50. PMID 21633782 DOI: 10.1007/S00223-011-9501-5  0.308
2011 Zhang M, Howard K, Winters A, Steavenson S, Anderson S, Smelt S, Doellgast G, Sheelo C, Stevens J, Kim H, Hamburger A, Sein A, Caughey DJ, Lee F, Hsu H, et al. Monoclonal antibodies to B and T lymphocyte attenuator (BTLA) have no effect on in vitro B cell proliferation and act to inhibit in vitro T cell proliferation when presented in a cis, but not trans, format relative to the activating stimulus. Clinical and Experimental Immunology. 163: 77-87. PMID 21078085 DOI: 10.1111/J.1365-2249.2010.04259.X  0.323
2009 Balamotis MA, Pennella MA, Stevens JL, Wasylyk B, Belmont AS, Berk AJ. Complexity in transcription control at the activation domain-mediator interface. Science Signaling. 2: ra20. PMID 19417216 DOI: 10.1126/Scisignal.1164302  0.752
2009 Yie J, Hecht R, Patel J, Stevens J, Wang W, Hawkins N, Steavenson S, Smith S, Winters D, Fisher S, Cai L, Belouski E, Chen C, Michaels ML, Li YS, et al. FGF21 N- and C-termini play different roles in receptor interaction and activation. Febs Letters. 583: 19-24. PMID 19059246 DOI: 10.1016/J.Febslet.2008.11.023  0.324
2009 Balamotis MA, Pennella MA, Stevens JL, Wasylyk B, Belmont AS, Berk AJ. Erratum: Complexity in transcription control at the activation domain-mediator interface (Science Signaling (2009) 89 (er8)) Science Signaling. 2. DOI: 10.1126/Scisignal.289Er8  0.721
2008 Wu X, Lemon B, Li X, Gupte J, Weiszmann J, Stevens J, Hawkins N, Shen W, Lindberg R, Chen JL, Tian H, Li Y. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors. The Journal of Biological Chemistry. 283: 33304-9. PMID 18829467 DOI: 10.1074/Jbc.M803319200  0.322
2007 Wu X, Ge H, Gupte J, Weiszmann J, Shimamoto G, Stevens J, Hawkins N, Lemon B, Shen W, Xu J, Veniant MM, Li YS, Lindberg R, Chen JL, Tian H, et al. Co-receptor requirements for fibroblast growth factor-19 signaling. The Journal of Biological Chemistry. 282: 29069-72. PMID 17711860 DOI: 10.1074/Jbc.C700130200  0.346
2005 Wang G, Balamotis MA, Stevens JL, Yamaguchi Y, Handa H, Berk AJ. Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. Molecular Cell. 17: 683-94. PMID 15749018 DOI: 10.1016/J.Molcel.2005.02.010  0.747
2004 Fang L, Stevens JL, Berk AJ, Spindler KR. Requirement of Sur2 for efficient replication of mouse adenovirus type 1. Journal of Virology. 78: 12888-900. PMID 15542641 DOI: 10.1128/Jvi.78.23.12888-12900.2004  0.574
2003 Cantin GT, Stevens JL, Berk AJ. Activation domain-mediator interactions promote transcription preinitiation complex assembly on promoter DNA. Proceedings of the National Academy of Sciences of the United States of America. 100: 12003-8. PMID 14506297 DOI: 10.1073/Pnas.2035253100  0.766
2002 Stevens JL, Cantin GT, Wang G, Shevchenko A, Shevchenko A, Berk AJ. Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit. Science (New York, N.Y.). 296: 755-8. PMID 11934987 DOI: 10.1126/Science.1068943  0.771
2001 Wang G, Cantin GT, Stevens JL, Berk AJ. Characterization of mediator complexes from HeLa cell nuclear extract. Molecular and Cellular Biology. 21: 4604-13. PMID 11416138 DOI: 10.1128/Mcb.21.14.4604-4613.2001  0.744
1996 Liu H, Lightfoot R, Stevens JL. Activation of heat shock factor by alkylating agents is triggered by glutathione depletion and oxidation of protein thiols Journal of Biological Chemistry. 271: 4805-4812. PMID 8617749 DOI: 10.1074/jbc.271.9.4805  0.313
Show low-probability matches.